LIN9 Antikörper (N-Term)
Kurzübersicht für LIN9 Antikörper (N-Term) (ABIN928462)
Target
Alle LIN9 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Kreuzreaktivität
- Maus, Ratte (Rattus), Frosch
-
Aufreinigung
- Purified
-
Immunogen
- LIN9 antibody was raised in rabbit using the N terminal of LIN9 as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
LIN9 Blocking Peptide, (ABIN5614460), is also available for use as a blocking control in assays to test for specificity of this LIN9 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- LIN9 (Lin-9 Homolog (LIN9))
-
Andere Bezeichnung
- LIN9
-
Hintergrund
- LIN9 belongs to the lin-9 family and acts as a tumor suppressor. It inhibits DNA synthesis. Its ability to inhibit oncogenic transformation is mediated through its association with RB1. LIN9 plays a role in the expression of genes required for the G1/S transition. Synonyms: Polyclonal LIN9 antibody, Anti-LIN9 antibody, lin-9 homolog, C. elegans antibody, BARA antibody, BARPsv antibody, Lin-9 antibody, TGS antibody, TGS1 antibody.
-
Pathways
- Zellzyklus, Mitotic G1-G1/S Phases
Target
-